Flamel Technologies (FLML) has had a string of rather good news. It recently received FDA approval for its drug Bloxiverz. What is even better is the fact that Flamel already has a rather substantial amount of income coming in for a small-cap stock. With all of this good news, there is still a large amount of upside potential left for this stock. The one main problem with Flamel Technologies is in the fact that it is hesitant to report key information about its drugs in development. This makes planning for the long term to be much more of a guessing game than usual (which is already a huge guessing game). However, this represents interesting catalysts depending on the market that is targeted by the respective drug.
Bloxiverz
Bloxiverz is a drug that is used to reverse the effects of the paralyzing drugs used during surgery. This drug is the first FDA approved version of neostigmine. This drug represents significant medium term upside potential for the stock as Flamel begins to add revenue, which should help share price. The product should be on the market very quickly, as a matter of fact according to recent press releases, Flamel is predicting a July launch of the drug.
Top Medical Companies To Watch For 2015: Bouygues SA (BOUYF.PK)
Bouygues SA is a France-based group that operates in two sectors: Telecommunications and Media, and Construction. The Construction division comprises three core subsidiaries: Bouygues Construction, specializing in building and public works activities, notably in the areas of electrical engineering, and facility maintenance; Bouygues Immobilier, a property development company, whose activities include the development of residential, corporate and commercial properties, and the execution of urban development schemes, and Colas, engaged in the construction and maintenance of transport, urban development and leisure infrastructure. The Telecommunications and Media division of the Group comprises two companies: TF1, specializing in audiovisual and cinema production, the acquisition and sale of audiovisual rights, and the publishing and distribution of compact discs, among others, and Bouygues Telecom, which offers mobile telephone and broadband Internet services. Advisors' Opinion:- [By Mike Arnold]
I normally don't look at charts much, but comparing Orange to its competitors in the French telecommunications market is quite fascinating. As one can see, incumbents Bouygues (BOUYF.PK) and Vivendi (VIVHY.PK) (owner of SFR) saw similar price declines. The market, on the other hand, rapidly bid up the price of new entrant Iliad SA (ILIAF.PK), as a result of forecasts for Iliad to capture significant mobile market share (which it did, around 10%). The wide divergence in price relative to changes in underlying value favor going long the incumbents, including Orange. Because this time it's different.
Hot Income Stocks To Watch For 2014: Spectrum Pharmaceuticals Inc.(SPPI)
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company, primarily focuses on oncology and hematology. The company engages in acquiring, developing, and commercializing a broad and diverse pipeline of late-stage clinical and commercial products. It markets Zevalin, a prescribed form of cancer therapy, radioimmunotherapy; and Fusilev, a novel folate analog formulation and the pharmacologically active isomer of the racemic compound, calcium leucovorin. The company?s drugs in late stage development include Apaziquone, an anti-cancer agent; and Belinostat, a histone deacytelase inhibitor. Its drugs in development also include Ozarelix a luteinizing hormone releasing hormone antagonist, which is in Phase II clinical stage; SPI-1620, a peptide agonist of endothelin B receptors, which is in Phase I clinical stage; and RenaZorb, a lanthanum-based nanoparticle phosphate binding agent, which is in preclinical stage. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is based in Henderson, Nevada.
Advisors' Opinion:- [By Keith Speights]
Another prime case study for this comes from Spectrum Pharmaceuticals (NASDAQ: SPPI ) . Spectrum's stock more than doubled from October 2011 through July 2012. However, shares plunged 55% from those highs because business dynamics changed since then. A shortage of a generic rival to Spectrum's lead drug Fusilev was alleviated, resulting in sales slowing down considerably.�
Hot Income Stocks To Watch For 2014: Sasol Ltd.(SSL)
Sasol Limited operates as an integrated energy and chemicals company worldwide. It mines saleable coal; distributes and markets natural gas and methane-rich gas; owns, operates, and maintains cross-border natural gas pipeline; produces coal-based synfuels; and markets oil products, such as petrol, diesel, jet fuel, illuminating paraffin, naphtha, liquid petroleum gas (LPG), fuel oils, bitumen, motor and industrial lubricants, and sulphur to the industrial and licensed wholesalers customers in South Africa. The company also supplies ethylene, propylene, polyethylene, polypropylene, polyvinyl chloride, chlor-alkali chemicals, and mining reagents; solvents, co-monomers, acrylates, and associated products; surfactants, linear alkylbenzene, surfactant intermediates, n-paraffins, n-olefins, C6-C22 alcohols, ethylene, oleochemicals, and other organic intermediates, as well as provides specialty aluminas, silica aluminas, and hydrotalcites. In addition, it produces and markets var ious chemical products comprising waxes, fertilizers, and mining explosive products; converts natural gas into synthesis gas for use as petrochemical feedstock; and involves in the research and development, alternative energy, and financial activities. Further, the company produces natural gas and condensate from the onshore Pande and Temane fields in Mozambique; oil in Gabon from the offshore Etame, Avouma, and Ebouri oilfield cluster; and shale gas from the Farrell Creek and Cypress A assets in Canada. It operates in South Africa, the other parts of Africa, Europe, North America, South America, Southeast Asia, Australasia, the Middle East, India, and the Far East. Sasol Limited was founded in 1950 and is headquartered in Johannesburg, South Africa.
Advisors' Opinion:- [By Dan Newman]
Profitable opportunity
Some may guess that doing business with developing countries wouldn't allow for a very profitable business. However, when South African companies like�Sasol� (NYSE: SSL ) �-- which estimated 18% of its workforce carried HIV in 2007�-- must dedicate departmental budgets to HIV/AIDS, there are plenty of opportunities for Female Health to cover costs and earn a return. A healthier workforce for Sasol would simply cost less for the company, and Female Health can help companies like Sasol achieve a healthier workforce. - [By Jeff Reeves]
If you want to play stocks directly, one great options is telecom play MTN Group�(MTNOY). Smartphones can provide even remote villages tremendous communications and commerce power to unlock growth, and MTN is a key part of that narrative across Africa. Chemicals and energy company Sasol (SSL) is more of a cyclical play but also headquartered in South Africa.
Hot Income Stocks To Watch For 2014: Universal Health Realty Income Trust (UHT)
Universal Health Realty Income Trust (Trust) is a real estate investment trust (REIT). It invests in health care and human service related facilities, including acute care hospitals, behavioral healthcare facilities, rehabilitation hospitals, sub-acute facilities, surgery centers, childcare centers and medical office buildings (MOBs). As of February 29, 2012, it had 54 real estate investments or commitments located in 15 states in the United States consisting of seven hospital facilities, including three acute care, one behavioral healthcare, one rehabilitation and two sub-acute; 43 MOBs, and four preschool and childcare centers. In February, 2012, Canyon Healthcare Properties, in which it owned a 95% non-controlling ownership interest, completed the divestiture of the Canyon Springs Medical Plaza. In January, 2012, it purchased the PeaceHealth Medical Clinic, a single-tenant medical office building consisting of approximately 99,000 rentable square feet, located in Bellingham, Washington. During the year ended December 31, 2011, the Company acquired Lake Pointe Medical Arts Building, Forney Medical Plaza, Tuscan Professional Building and Emory at Dunwoody Building, and minority ownership interests held by third-party members in 11 limited liability companies (LLCs). On November 30, 2011 and December 16, 2011, eight LLCs in which it owned various non-controlling, ownership interests, completed the divestitures of medical office buildings and related real property.
As of February 29, 2012, the Company had investments in 54 facilities, located in 15 states and consisting of Southwest Healthcare System, Inland Valley Campus, McAllen Medical Center, Wellington Regional Medical Center, The Bridgeway, Kindred Hospital Chicago Central, Kindred Hospital Corpus Christi, HealthSouth Deaconess Rehabilitation Hospital, Family Doctor�� Medical Office Bldg., Kelsey-Seybold Clinic at Kings Crossing, Professional Bldgs. at Kings Crossing Building A and Building B, Chesterbrook Academy, Southern Cresce! nt Center I, Desert Valley Medical Center, Desert Springs Medical Plaza, and Santa Fe Professional Plaza. As of December 31, 2011, included in its portfolio are seven hospital facilities. During 2011, the leases with respect to these hospital facilities consisted approximately 65% of its revenue. As of December 31, 2011, these leases have fixed terms with an average of 4.4 years remaining and include renewal options ranging from one to five, five-year terms. During 2011, revenues generated from the leases on the Universal Health Services, Inc. (UHS) hospital facilities accounted for approximately 55% of its total revenue. During 2011, it had a total of 41 new or renewed leases related to the medical office buildings.
Advisors' Opinion:- [By Dividends4Life]
Related Articles:
- Universal HealthRealty Income Trust (UHT) Dividend Stock Analysis
- ConocoPhillips Co. (COP) Dividend Stock Analysis
- W.W. Grainger, Inc. (GWW) Dividend Stock Analysis
- AFLAC Incorporated (AFL) Dividend Stock Analysis
- More Stock Analysis - [By Dividends4Life]
Linked here is a detailed quantitative analysis of Universal HealthRealty Income Trust (UHT). Below are some highlights from the above linked analysis:
- [By Eric Volkman]
Universal Health Realty Income Trust (NYSE: UHT ) is building on the foundation of its shareholder payouts with a modest increase. The company has declared a quarterly dividend of $0.625 per share, to be paid on June 28 to shareholders of record as of June 17. That amount is half a penny higher than the company's previous two disbursements of $0.62 apiece, the most recent of which was handed out in late March.
Hot Income Stocks To Watch For 2014: Cenkos Securities PLC (CNKS)
Cenkos Securities plc (Cenkos) is an independent, specialist institutional securities group, focused on growth companies and investment funds. The Company�� principal activities comprise of corporate broking and advisory and institutional equities. Corporate Broking and Advisory segment reflects the corporate finance, corporate broking and market making services provided to growth companies and investment funds. Institutional Equities segment reflects the institutional equities team who provide research-driven investment recommendations and execution capabilities to institutional clients. Cenkos earns fees from primary and secondary equity fund raising, acting as a key intermediary between growth companies or investment funds and institutional providers of capital. Revenue in Corporate Broking and Advisory segment is made up of placing commissions on fund raisings, corporate finance fees and retainer income, market making profits and commissions on secondary market transactions. Advisors' Opinion:- [By Trista Kelley]
Cenkos Securities Plc (CNKS) is running the spinoff and the share sale. Royal DSM NV (DSM), the world�� largest maker of vitamins, holds about 9 percent of SiS, while U.K. venture-capital trust Downing LLP owns 16.7 percent, Moon said. Provexis stockholders received one share of Science in Sport for every 100 shares of Provexis.
No comments:
Post a Comment